Atenolol                                                                                                         Analysis, Process, Patent, Consultants, Functions, Product, Suppliers, Report                                                                 Primary Information Services                                                   Home. Ordering Information. Contact

Information @ a Glance

Contents on the CD Rom

  • Atenolol is a 1 receptor specific antagonist, a drug belonging to the group of -blockers, a class of drugs used primarily in cardiovascular diseases.
  • Atenolol was developed as a replacement for propranolol in the treatment of hypertension.
  • The chemical works by slowing down the heart and reducing its workload.
  • Atenolol does not pass through the blood-brain barrier thus avoiding various CNS side effects.
  • Atenolol causes significantly fewer central nervous system side effects and fewer bronchospastic reactions, both due to its particular pharmacologic profile.
  • If atenolol alone fails to control arterial hypertension, the drug can be combined with a diuretic or a vasodilator.
  • Atenolol is a member of a class of drugs known as beta-blockers.
  • Atenolol nanoparticles were prepared successfully by DESE technique using EC and PVA.
  • Atenolol acts to inhibit the action of adrenaline on the heart and thereby slows the heart and lowers blood pressure.
  • Therapeutic doses may produce side effects such as dizziness, muscular fatigue, coldness of the fingers and toes, and difficulty in breathing, and/or aggravation of asthma.
  • A HPLC system using RP -C18 column and fluorescence detector was used to assess atenolol in plasma.
  • DESE method involves the dispersion of the aqueous solution of atenolol in a solution of ethylcellulose in dichloromethane.
General Information
  • Information about Atenolol
  • Description about Atenolol
  • Fact Sheet about Atenolol
  • Atenolol tablets

Consultant

  • Consultant from California
  • Consultant from Carolina
  • Consultant from Florida
  • Consultant from Minnesota
  • Consultant from Newyork
  • Consultant from India

Process

  • Simultaneous Quantitation of Atenolol, Metoprolol, and Propranolol in Biological Matrices Via LC/MS
  • Electro-oxidation of Atenolol at a Glassy Carbon Electrode
  • Preparation and Characterization of an Atenolol Selective Electrode Based on a PVC Matrix Membrane

MSDS

  • Atenolol MSDS
  • Safety data for atenolol
  • MSDS for Atenolol

Product

  • Chemmart Atenolol
  • GenRx Atenolol
  • Pms-Atenolol
  • Tekturna
  • Tenormin

Suppliers

  • Suppliers of Atenolol
  • Atenolol manufacturers
  • Manufacturers of Atenolol
  • Selling leads of Atenolol
  • Tradeleads of Atenolol
Buyers
  • Buyers List1

Functions

  • Effects of Atenolol and Propranolol on Platelet Aggregation in Moderate Essential Hypertension
  • The In vitro Effects of Atenolol and Zinc Chloride on the Protein Binding of Amlodipine in Aqueous Medium
Patent
  • Process for producing atenolol of high optical purity
  • Process for producing optically active atenolol and intermediate thereof
  • Phase transfer catalytic process for preparing intermediates of atenolol
Report
  • Bioequivalence study of Atenolol
  • Ultrastructural changes in the remnant kidney glomerulus after losartan and atenolol treatment
  • Nursing Process Focus
  • Atenolol quantification in human plasma by high performance liquid chromatography
  • Atenolol injection at the lateral septum does not inhibit male sexual behavior in rats
  • Development Characterization and In Vitro Release of Atenolol Nanoparticles

Order The CD-ROM Today

Primary Information Services
 21 Murugappan St, SwamyNagar Ext2, 
Ullagaram, Chennai - 600091, India.
 Phone: 91 44 22421080 
Email : informer@eth.net
Mobile numbers:9940043898, 9444008898  Fax : 91 44 22423753